from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2857c/-

LFCtreatmentdescriptionclass of inhibitor

0.090

Amikacinug/mL Amikacintranslation

-0.637

Cap5-10ug/mL Capreomycintranslation

-0.132

Rox10-50 ug/mL Roxithromycintranslation

0.223

SM2-5 ug/mL Streptomycintranslation

0.910

Tet5-10 ug/mL Tetracyclinetranslation

1.582

Rif0.2-5ug/mL Rifampicintranscription

0.037

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.480

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.069

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.188

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.631

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.299

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.572

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.670

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.443

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.381

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.351

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.649

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.847

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.154

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.069

KCN5-20 ug/mL Potassium cyaniderespiration

-0.755

NaN30.2-2 mM Sodium aziderespiration

0.222

Nigericin50 uM Nigericinrespiration

-0.453

TRC10-150 ug/mL Triclosanrespiration

-1.520

TRZ10-25 ug/mL Thioridazinerespiration

-0.166

Valinomycin0.5-10 uM Valinomycinrespiration

0.373

ZnSO42 mM ZnSO4respiration

0.427

menadione6-10 ug/mL Menadionerespiration

-0.143

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.219

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.203

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.171

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.759

NRP_1Non-replicating persistence stage 1dosRassociated

0.654

Amp0.2mg/mL AmpicillincellWall

0.122

Cephalexin20-100 ug/mL CephalexincellWall

0.164

Cerulenin0.32-5 ug/mL CerulenincellWall

1.304

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.820

EMB10-20 ug/mL EthambutolcellWall

0.658

Eta12-40 ug/mL EthionamidecellWall

0.797

INH0.2-0.4 ug/mL IsoniazidcellWall

0.790

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.677

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.251

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.394

BZA0.12 mg/mL BenzamidearomaticAmides

-0.256

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.036

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.436

H2O24 mM hydrogen peroxideDNAdamaging

0.080

Levo10 ug/mL LevofloxacinDNAdamaging

0.241

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.415

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.377

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.034

UVUV-irradiationDNAdamaging

-1.231

ARP41-4 ug/mL Antitubercular compound ARP4?

0.271

Antimycin12.5-50 ug/mL Antimycin A?

-0.428

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.176

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.359

PA8240.2-2 ug/mL PA-824?

-0.899

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.010

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.287

Verapamil50 uM Verapamil?

0.132

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.086

methoxatin10-20 ug/mL Methoxatin?